Literature DB >> 14982744

Levels of human immunodeficiency virus type 1 (HIV-1) replication in macrophages determines the severity of murine HIV-1 encephalitis.

Adeline Nukuna1, Howard E Gendelman, Jenae Limoges, Jennifer Rasmussen, Larisa Poluektova, Anuja Ghorpade, Yuri Persidsky.   

Abstract

The presence of specific neuroinvasive strains and necessity for brain viral replication for disease progression remain controversial issues in neuro-AIDS research. To investigate these questions, the authors injected human monocyte-derived macrophages (MDMs) infected with diverse viral strains were injected into the caudate and putamen of severe combined immunodeficient (SCID) mice. Independent of viral strain, infected MDMs became immunologically activated and elicited profound inflammatory reactions in brain areas most affected in humans. The intensity of neuropathologic changes, including microglial reactions, paralleled levels of viral infection and numbers of infected MDMs. The data suggest that HIV-1-associated neurological disease is related to the level of productive viral infection in activated macrophages. Virus infection, per se, may affect the ability of macrophages to respond to immune stimuli by overproduction of proinflammatory factors and neurotoxins, leading to neuronal dysfunction.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14982744     DOI: 10.1080/753312757

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  41 in total

1.  HIV-related neuropathology, 1985 to 1999: rising prevalence of HIV encephalopathy in the era of highly active antiretroviral therapy.

Authors:  Jutta K Neuenburg; Hans R Brodt; Brian G Herndier; Markus Bickel; Peter Bacchetti; Richard W Price; Robert M Grant; Wolfgang Schlote
Journal:  J Acquir Immune Defic Syndr       Date:  2002-10-01       Impact factor: 3.731

2.  The role of mononuclear phagocytes in HTLV-III/LAV infection.

Authors:  S Gartner; P Markovits; D M Markovitz; M H Kaplan; R C Gallo; M Popovic
Journal:  Science       Date:  1986-07-11       Impact factor: 47.728

3.  Cortical synaptic density is reduced in mild to moderate human immunodeficiency virus neurocognitive disorder. HNRC Group. HIV Neurobehavioral Research Center.

Authors:  I P Everall; R K Heaton; T D Marcotte; R J Ellis; J A McCutchan; J H Atkinson; I Grant; M Mallory; E Masliah
Journal:  Brain Pathol       Date:  1999-04       Impact factor: 6.508

4.  Human immunodeficiency virus encephalitis in SCID mice.

Authors:  Y Persidsky; J Limoges; R McComb; P Bock; T Baldwin; W Tyor; A Patil; H S Nottet; L Epstein; H Gelbard; E Flanagan; J Reinhard; S J Pirruccello; H E Gendelman
Journal:  Am J Pathol       Date:  1996-09       Impact factor: 4.307

5.  Neurocognitive dysfunction predicts postmortem findings of HIV encephalitis.

Authors:  M Cherner; E Masliah; R J Ellis; T D Marcotte; D J Moore; I Grant; R K Heaton
Journal:  Neurology       Date:  2002-11-26       Impact factor: 9.910

6.  Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide.

Authors:  D E Brenneman; G L Westbrook; S P Fitzgerald; D L Ennist; K L Elkins; M R Ruff; C B Pert
Journal:  Nature       Date:  1988-10-13       Impact factor: 49.962

7.  Human immunodeficiency virus type 1 Tat protein induces death by apoptosis in primary human neuron cultures.

Authors:  D R New; M Ma; L G Epstein; A Nath; H A Gelbard
Journal:  J Neurovirol       Date:  1997-04       Impact factor: 2.643

8.  A regulatory role for astrocytes in HIV-1 encephalitis. An overexpression of eicosanoids, platelet-activating factor, and tumor necrosis factor-alpha by activated HIV-1-infected monocytes is attenuated by primary human astrocytes.

Authors:  H S Nottet; M Jett; C R Flanagan; Q H Zhai; Y Persidsky; A Rizzino; E W Bernton; P Genis; T Baldwin; J Schwartz
Journal:  J Immunol       Date:  1995-04-01       Impact factor: 5.422

Review 9.  The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex.

Authors:  R W Price; B Brew; J Sidtis; M Rosenblum; A C Scheck; P Cleary
Journal:  Science       Date:  1988-02-05       Impact factor: 47.728

Review 10.  Chemokine receptors in HIV-1 infection of the central nervous system.

Authors:  D Gabuzda; J He; A Ohagen; A V Vallat
Journal:  Semin Immunol       Date:  1998-06       Impact factor: 11.130

View more
  17 in total

Review 1.  Viral and host genetic factors regulating HIV/CNS disease.

Authors:  Jeymohan Joseph; Toby Behar
Journal:  J Neurovirol       Date:  2004       Impact factor: 2.643

Review 2.  Rodent models for HIV-associated neurocognitive disorders.

Authors:  Santhi Gorantla; Larisa Poluektova; Howard E Gendelman
Journal:  Trends Neurosci       Date:  2012-02-01       Impact factor: 13.837

Review 3.  Brain dysfunction in the era of combination antiretroviral therapy: implications for the treatment of the aging population of HIV-infected individuals.

Authors:  Uraina S Clark; Ronald A Cohen
Journal:  Curr Opin Investig Drugs       Date:  2010-08

4.  Nano-NRTIs: efficient inhibitors of HIV type-1 in macrophages with a reduced mitochondrial toxicity.

Authors:  Serguei V Vinogradov; Larisa Y Poluektova; Edward Makarov; Trevor Gerson; Madapathage T Senanayake
Journal:  Antivir Chem Chemother       Date:  2010-10-28

5.  Amphiphilic cationic nanogels as brain-targeted carriers for activated nucleoside reverse transcriptase inhibitors.

Authors:  G Warren; E Makarov; Y Lu; T Senanayake; K Rivera; S Gorantla; L Y Poluektova; S V Vinogradov
Journal:  J Neuroimmune Pharmacol       Date:  2015-01-06       Impact factor: 4.147

6.  Links between progressive HIV-1 infection of humanized mice and viral neuropathogenesis.

Authors:  Santhi Gorantla; Edward Makarov; Jennifer Finke-Dwyer; Antonio Castanedo; Adelina Holguin; Catherine L Gebhart; Howard E Gendelman; Larisa Poluektova
Journal:  Am J Pathol       Date:  2010-11-18       Impact factor: 4.307

7.  Plasma cytokine concentrations associated with HIV/hepatitis C coinfection are related to attention, executive and psychomotor functioning.

Authors:  Ronald A Cohen; Suzanne de la Monte; Assawin Gongvatana; Hernando Ombao; Beverly Gonzalez; Kathryn N Devlin; Bradford Navia; Karen T Tashima
Journal:  J Neuroimmunol       Date:  2010-12-10       Impact factor: 3.478

8.  Relationship of plasma cytokines and clinical biomarkers to memory performance in HIV.

Authors:  Stephen Correia; Ronald Cohen; Assawin Gongvatana; Skye Ross; James Olchowski; Kathryn Devlin; Karen Tashima; Bradford Navia; Suzanne Delamonte
Journal:  J Neuroimmunol       Date:  2013-09-27       Impact factor: 3.478

9.  Neuroprotective activities of CEP-1347 in models of neuroAIDS.

Authors:  Dawn Eggert; Prasanta K Dash; Santhi Gorantla; Huanyu Dou; Giovanni Schifitto; Sanjay B Maggirwar; Stephen Dewhurst; Larisa Poluektova; Harris A Gelbard; Howard E Gendelman
Journal:  J Immunol       Date:  2009-12-04       Impact factor: 5.422

10.  Nanogel-Conjugated Reverse Transcriptase Inhibitors and Their Combinations as Novel Antiviral Agents with Increased Efficacy against HIV-1 Infection.

Authors:  T H Senanayake; S Gorantla; E Makarov; Y Lu; G Warren; S V Vinogradov
Journal:  Mol Pharm       Date:  2015-11-13       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.